Gland Pharma Ltd.

Financial

	Gland Pharma	Caplin Point Lab	Gufic Biosciences
Operational Metrics
API Sector
US DMF Filings	67.0 .	n/a	n/a
Pharmaceutical Sector
Number of ANDA's Filed in USA	349.0 .	41.0 .	n/a
Number of ANDA's Approved By USFDA	286.0 .	27.0 .	n/a
Unclassified
R&D as a % of Total Sales	3.7 %	5.4 %	1.06 %
API Capacity	11000.0 Kg/Year	n/a	n/a
Financials
5 yr Average ROE	16.21 %	22.25 %	26.14 %
5yr average Equity Multiplier	1.1	1.17	2.82
5yr Average Asset Turnover Ratio	0.54	0.76	1.1
5yr Avg Net Profit Margin	26.8 %	24.85 %	9.03 %
Price to Book	3.42	4.76	6.69
P/E	38.64	24.12	41.38
5yr Avg Cash Conversion Cycle	141.92 Days	64.48 Days	-18.02 Days
Inventory Days	117.9 Days	54.23 Days	77.22 Days
Days Receivable	97.99 Days	88.48 Days	81.36 Days
Days Payable	98.36 Days	76.0 Days	175.58 Days
5yr Average Interest Coverage Ratio	245.99	513.03	10.3
5yr Avg ROCE	21.37 %	27.4 %	33.27 %
5yr Avg Operating Profit Margin	39.34 %	34.96 %	17.37 %
5 yr average Debt to Equity	0.0	0.01	0.73
5yr CAGR Net Profit	0.21 %	16.34 %	29.43 %
5yr Average Return on Assets	14.66 %	19.05 %	10.17 %
Shareholdings
Promoter Holding	57.86 %	70.62 %	72.51 %
Share Pledged by Promoters	0.0	0.0	0.0
Change in Promoter Holding (3 Yrs)	-0.39 %	1.59 %	6.76 %
Change in Mutual Fund Holding (3 Yrs)	12.81 %	0.61 %	-6.16 %

Business

	Gland Pharma	Caplin Point Lab	Gufic Biosciences
Product Wise Break-Up	Product Wise Break-Up Pharmaceutical 100.0 Injectables 0 Branded Generic 0 Generic 0 API 0 Muscle Relaxants 0 Cardiovascular 0 Proton pump inhibitors 0 Anti-fungals 0 Anti-bacterials 0 International 0 CMO 0 Domestic 0	Product Wise Break-Up API 0 Pharmaceutical 0 Anti-fungals 0 Branded Generics 25.0 Formulations 75.0 International 0 Injectables 0 Domestic 0 Anti-bacterials 0 CMO 0 Muscle Relaxants 0 Cardiovascular 0 Proton pump inhibitors 0	Product Wise Break-Up Active Pharmaceutical Ingredient (API) 5.0 Pharmaceutical 0 Anti-fungals 0 Branded Generic 0 Generic 0 International 15.0 Injectables 0 Domestic Pharmaceuticals 50.0 Anti-bacterials 0 CMO 30.0 Muscle Relaxants 0 Cardiovascular 0 Proton pump inhibitors 0
Location Wise Break-Up	Location Wise Break-Up USA 57.13 Europe 17.46 Canada, Australia & New Zealand 3.76 India 3.42 Australia 0 Canada 0 Africa 0 LATAM 0 South America 0 North America 0 Asia 0 Rest of the World 0 Others 18.23	Location Wise Break-Up North America 0 Asia 0 Rest of the World 0 Canada, Australia & New Zealand 0 USA 18.0 Africa 2.0 South America 0 Latin America 80.0 Australia 0 Europe 0 Canada 0 India 0	Location Wise Break-Up North America 1.68 Asia Pacific 7.41 Rest of the World 0 Canada, Australia & New Zealand 0 USA 0 Africa 1.94 South America 0.11 LATAM 0 Australia 0.08 Europe 4.26 Canada 0 India 84.52
Distribution Channel	Distribution Channel B2B 97.51 B2C 2.49 Tender Business 0 Pharmacy Sales 0 Distributors 0	Distribution Channel Tender Business 20.0 Pharmacy and Dietary 25.0 Distribution 55.0 B2C 0 B2B 0	-

Gland Pharma Ltd.

SIGN UP FOR FREE